1. Hypertension Flashcards

1
Q

What is Hypertension?

A

Persistent elevation of blood pressure at or above 140/90 mmHg, confirmed by multiple readings over time or 24-hour ambulatory monitoring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What characterises stage 1 hypertension?

A

Clinic blood pressure ranging from 140/90 - 159/99mmHg and ABPM daytime average ranging from 135/85 - 149/94 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What characterises stage 2 hypertension?

A

Clinic blood pressure ranging from 160/100 - 180/120mmHg and ABPM daytime average of 150/95 or higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Ambulatory Blood Pressure Monitoring (ABPM)?

A

-Ambulatory Blood Pressure Monitoring (ABPM) involves measuring blood pressure over 24 hours
-A small, portable device automatically takes readings at regular intervals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the benefit of ABPM?

A

-Detects white coat hypertension
-Identifies masked hypertension
-Assesses BP variations throughout the day and night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the reflex through which high blood pressure is controlled?

A

-Baroreceptors in carotid sinus and aortic arch sense increased arterial pressure
-Activates the medulla oblangata, increasing parasympathetic output (slowing the heart rate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why does the baroreceptor reflex fail in those with hypertension?

A

In chronic hypertension, barorecetpros adapt to the elevated blood pressure, treating it as the new normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do
-⍺1
-β1
adrenergic receptor stimulation lead to?

A

-⍺1: Vasoconstriction
-β1: Increased force of contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is essential (primary) hypertension caused by?

A

-Unknown cause
-Hereditary links help predict it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is accelerated (malignant) hypertension?

A

-Severe, rapidly progressing hypertension (BP >180/120mmHg)
-Leads to organ damage, cardiovascular events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is secondary hypertension caused by?

A

-Sleep apnoea
-Kidney disease (eg CKD)
-Thyroid disease (eg hyper/hypothyroidism)
-Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What releases Renin, and what is the action of this?

A

-Kidney releases renin
-Renin converts angiotensinogen to angiotensin I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What creates angiotensin II?

A

ACE enzyme converts angiotensin I to angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the action of angiotensin II?

A

-Stimulates aldosterone release from adrenal cortex (promotes sodium retention)
-Causes release of ADH from pituitary (promotes water retention)
-Stimulates thirst (fluid and blood volume increase)
-Causes vasoconstriction
-Cardiac and vascular hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the targets for the treatments of hypertension?

A

-Renin Angiotensin Aldosterone pathway
-Angiotensin II receptors
-Na reabsorption mechanisms in kidney
-Adrenergic receptors
-Calcium channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe ACE inhibitors as a treatment for hypertension

A

-Inhibits the angiotensin converting enzyme in the renin-angiotensin-aldosterone pathway
-Decreases vasoconstriction and salt retention
-Also inhibits bradykinin breakdown, leading to extra vasodilation

16
Q

Give an example of an ACE inhibitor, and describe its pharmacokinetics

A

-Lisinopril
-Absorbed slowly from GI tract, with 25% bioavailability, and peak plasma concentration reached in 6-8 hours
-Water soluble, meaning it is not metabolised and undergoes renal excretion.

17
Q

Give some side effects associated with lisinopril

A

-DRY COUGH
-Postural disorders
-Hallucination
-Altered mood
-Raynaud’s phenomenon
-Anaemia
-Hypersensitivity
-Hypoglycaemia

18
Q

Describe ARBs as a treatment for hypertension

A

-Angiotensin II Receptor Blockers
-Selectively blocking AT1 receptors, preventing the effects of angiotensin II, which include
-Vasoconstriction, aldosterone release and sympathetic activation

19
Q

Give an example of an ARB, and its pharmacokinetics

A

-Losartan
-Orally administered, with 33% bioavailability, and peak plasma conc reached in 1-3 hours
-Metabolised in liver to form its active metabolite which has half life of 3-9 hours
-Extensive albumin binding, and excreted in urine and bile

20
Q

Give some side effects associated with losartan

A

-Anaemia
-Hypoglycaemia
-Postural disorders
-Hyperkalaemia

21
Q

Describe calcium channel blockers as a treatment for hypertension

A

-Calcium voltage gated channel blockers, inhibiting the influx of calcium ions
-Acting on myocardial muscle (inhibiting contractility)
-Acting on myocardial conducting system (inhibiting CICR)
-Acting on vascular smooth muscle (vasodilation)

22
Q

Give an example of a calcium channel blocker, and its pharmacokinetics

A

-Amlodipine
-Orally administered with 60% bioavailability, half life of 30-50 hours
-Steady state plasma concentrations reached after 7 days of daily dosing
-Poorly eliminated

23
Q

Which groups are ARBs or ACE inhibitors used in to treat hypertension?

A

-Age <55 and not of black African or African–Caribbean family origin
-Type II diabetics with hypertension

24
Q

Which groups are CCBs used in to treat hypertension?

A

-Aged 55 and over
-Black African or African–Caribbean family origin (any age)

25
Q

How may diabetes lead to hypertension?

A

-Diabetes damages the kidneys, reducing their ability to excrete sodium and water, increasing blood volume and hypertension
-May also damage peripheral micro vessels

26
Q

If the first treatment (ACEi or ARB or CCB) in hypertension is ineffective, what should be done after?

A

-Kept on preexisting treatment
-Add extra treatment (ACEi, ARB or CCB or thiazide like diuretic)
-If this is ineffective, if low K+ levels add sprinonolactone and/or alpha/beta blockers

27
Q

Describe the mechanism of action of thiazide-like diuretics

A

-Inhibit the Na+/Cl- symporter in the distal convoluted tubule, preventing reabsorption, leading to increased sodium excretion in the urine
-Water follows sodium osmotically, leading to diuresis, increasing urine output and frequency
-This reduces plasma volume, lowering blood pressure
-Thiazide like diuretics also induce vasodilation, reducing peripheral vascular resistance

28
Q

Give an example of thiazide like diuretic, and its pharmacokinetics

A

-eg Indapamide
-Orally administered with high bioavailability, and 1-2 hours to reach peak plasma conc
-Metabolised by CYP3A4, with elimination half life of 14-18 hours, supporting once-daily dosing

29
Q

Give some of the adverse reactions associated with thiazide like diuretics

A

-Elderly are particularly sensitive to hypokalaemia (dangerous in severe cardiovascular disease and being treated with cardiac glycosides)
-Elderly are also sensitive to constipation, electrolyte imbalance, headache and postural hypotension
-INDAPAMIDE specifically causes hypersensitivity and skin reactions

30
Q

Why do thiazide like diuretics cause hypokalaemia?

A

-Thiazide like diuretics increase concentration of sodium in the tubule
-More sodium hence reaches the collecting duct, where Na+/K+ exchangers are present, driving exchange of sodium for potassium (more is excreted in urine)

31
Q

Describe the mechanism of action of spironolactone diuretics

A

-Potassium sparing diuretic
-Competitive antagonist of aldosterone to the mineralocorticoid receptor
-Aldosterone is unable to activate the Na+/K+ ATPase pump, reducing sodium reabsorption and potassium secretion
-This reduces blood volume, reducing blood pressure, as well as reducing aldosterone mediated vasoconstriction

32
Q

Who should spironolactone diuretics NOT be used in?

A

Those with high serum levels of potassium

33
Q

Describe the mechanism of action of Alpha-1 receptor blockers in the treatment of hypertension

A

-Alpha 1 receptors located in smooth muscle of blood vessels are blocked, preventing noradrenaline mediated vasoconstriction
-This leads to vasodilation and a reduction in systemic vascular resistance and blood pressure
-Also helps to prevent the baroreceptor reflex, preventing vasoconstriction

34
Q

Describe the mechanism of action of Beta 1 receptor blockers in the treatment of hypertension

A

-Beta 1 receptors located in SAN, AVN and myocardial cells are blocked, preventing noradrenaline and adrenaline binding, reducing the sympathetic response.
-This reduces heart rate, contractility and cardiac output, leading to a reduction in blood pressure
-ALSO when beta 1 receptors in kidneys are blocked, renin secretion is reduced, leading to lower angiotensin II levels.

35
Q

Give side effects associated with alpha 1 receptor blockers

A

-Postural hypotension
-Reflex tachycardia
-Dizziness and fatigue
-Headache

36
Q

Give side effects associated with beta 1 receptor blockers

A

-Bradycardia
-Fatigue and exercise intolerance

37
Q

Why may beta 1 receptor blockers be considered in younger people?

A

-Intolerance or contraindication of ACE inhibitors and ARBs
-Women of childbearing potential
-Evidence of increased sympathetic drive